Global Pharma
- All
- News
- Videos
-
Corporate India To See 9.1% Salary Hike In 2026: Report
Corporate India is expected to roll out an average salary increase of 9.1 per cent in 2026, with Global Capability Centres (GCCs) leading the growth in pay, a new report said on Monday.
-
India-US Trade Deal Likely To Offer Tariff Relief On Exported Medicines
India's pharmaceutical industry has welcomed the interim trade agreement framework between India and the US, which offers tariff relief on medicines and several other Indian exports.
-
India-EU Trade Pact Explained: $572 Billion Boost To Indian Pharma, MedTech Industry
The India-EU Free Trade Agreement opens access to the European Union's $572.3 billion pharmaceuticals and medical devices market, boosting India's pharma sector, employment, MSMEs and global supply chain integration, according to the government.
-
India's Drug Standards Gain Global Recognition, Rise From 123rd To 8th Spot: Union Health Minister
India has risen to 8th position globally from 123rd in the World Health Organizations (WHO) pharmacovigilance contributions, said Union Minister for Health and Family Welfare J. P. Nadda on Friday.
-
India To Become Global Innovation-Led Pharma Giant In 5 Years: Central Drugs Body Says
India is well positioned to evolve from being the pharmacy of the world to an innovation-led pharma nation over the next five years, said Dr. R Chandrashekar, Joint Drugs Controller, the Central Drugs Standard Control Organization (CDSCO).
-
Who Is Rama Raju Mantena? The Indian-American Pharma Titan Behind Viral Udaipur Wedding
Rama Raju Mantena is a prominent figure in the US pharmaceutical industry, serving as the Chairman and CEO of Ingenus Pharmaceuticals, a company with operations in the US, Switzerland, and India.
-
Countries And Companies Threatened By Trump's 100% Tariffs On Pharma
Donald Trump has shocked the global drug industry by announcing 100-percent tariffs on all branded, imported pharmaceutical products -- unless companies are building manufacturing plants in the United States.
-
Why Trump's 100% Pharma Tariffs May Not Impact Indian Drugmakers Much
US President Donald Trump has said his administration will impose 100 per cent import tariffs on branded or patented pharmaceutical drugs from October 1, unless the pharma companies have or are building their manufacturing units in America.
-
Trump Declares 100% Tariff On Pharma Imports From October 1, India May Be Hit
US President Donald Trump has announced tariffs of up to 100 per cent on imports of branded and patented pharmaceutical products from October 1. India's pharmaceuticals sector, one of the most dependent domestic industries on trade with America.
-
India, Brazil Can Turn US Tariffs Into Opportunities For Deeper Cooperation: Brazilian Envoy
In an exclusive interview with IANS, Brazil's Ambassador to India, Kenneth Felix Haczynski Da Nobrega, emphasised that India and Brazil are working to turn current global economic challenges, into new opportunities for deeper bilateral cooperation.
-
Corporate India To See 9.1% Salary Hike In 2026: Report
Corporate India is expected to roll out an average salary increase of 9.1 per cent in 2026, with Global Capability Centres (GCCs) leading the growth in pay, a new report said on Monday.
-
India-US Trade Deal Likely To Offer Tariff Relief On Exported Medicines
India's pharmaceutical industry has welcomed the interim trade agreement framework between India and the US, which offers tariff relief on medicines and several other Indian exports.
-
India-EU Trade Pact Explained: $572 Billion Boost To Indian Pharma, MedTech Industry
The India-EU Free Trade Agreement opens access to the European Union's $572.3 billion pharmaceuticals and medical devices market, boosting India's pharma sector, employment, MSMEs and global supply chain integration, according to the government.
-
India's Drug Standards Gain Global Recognition, Rise From 123rd To 8th Spot: Union Health Minister
India has risen to 8th position globally from 123rd in the World Health Organizations (WHO) pharmacovigilance contributions, said Union Minister for Health and Family Welfare J. P. Nadda on Friday.
-
India To Become Global Innovation-Led Pharma Giant In 5 Years: Central Drugs Body Says
India is well positioned to evolve from being the pharmacy of the world to an innovation-led pharma nation over the next five years, said Dr. R Chandrashekar, Joint Drugs Controller, the Central Drugs Standard Control Organization (CDSCO).
-
Who Is Rama Raju Mantena? The Indian-American Pharma Titan Behind Viral Udaipur Wedding
Rama Raju Mantena is a prominent figure in the US pharmaceutical industry, serving as the Chairman and CEO of Ingenus Pharmaceuticals, a company with operations in the US, Switzerland, and India.
-
Countries And Companies Threatened By Trump's 100% Tariffs On Pharma
Donald Trump has shocked the global drug industry by announcing 100-percent tariffs on all branded, imported pharmaceutical products -- unless companies are building manufacturing plants in the United States.
-
Why Trump's 100% Pharma Tariffs May Not Impact Indian Drugmakers Much
US President Donald Trump has said his administration will impose 100 per cent import tariffs on branded or patented pharmaceutical drugs from October 1, unless the pharma companies have or are building their manufacturing units in America.
-
Trump Declares 100% Tariff On Pharma Imports From October 1, India May Be Hit
US President Donald Trump has announced tariffs of up to 100 per cent on imports of branded and patented pharmaceutical products from October 1. India's pharmaceuticals sector, one of the most dependent domestic industries on trade with America.
-
India, Brazil Can Turn US Tariffs Into Opportunities For Deeper Cooperation: Brazilian Envoy
In an exclusive interview with IANS, Brazil's Ambassador to India, Kenneth Felix Haczynski Da Nobrega, emphasised that India and Brazil are working to turn current global economic challenges, into new opportunities for deeper bilateral cooperation.
